Amdocs Historical Balance Sheet

DOX Stock

USD 81.97 0.17 0.21%

Trend analysis of Amdocs balance sheet accounts such as Other Current Liabilities of 1 B or Total Current Liabilities of 1 B provides information on Amdocs' total assets, liabilities, and equity, which is the actual value of Amdocs to its prevalent stockholders. By breaking down trends over time using Amdocs balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Amdocs latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Amdocs is a good buy for the upcoming year.

Amdocs Inventory

1.21

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

About Amdocs Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Amdocs at a specified time, usually calculated after every quarter, six months, or one year. Amdocs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Amdocs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Amdocs currently owns. An asset can also be divided into two categories, current and non-current.

Amdocs Balance Sheet Chart

Amdocs Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Amdocs uses and utilizes its capital. It also shows what exactly a company owns and owes.

At this time, Amdocs' Non Current Liabilities Total is fairly stable compared to the past year. Other Current Assets is likely to rise to about 307 M in 2024, whereas Total Assets are likely to drop slightly above 4.5 B in 2024.

Total Assets Short Long Term Debt Total Total Current Liabilities Total Stockholder Equity Accounts Payable Net Invested Capital

Add Fundamental

Total Assets

Total assets refers to the total amount of Amdocs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Amdocs books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Amdocs balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Amdocs are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Accounts Payable

An accounting item on the balance sheet that represents Amdocs obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Amdocs are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Most accounts from Amdocs' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Amdocs current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.At this time, Amdocs' Non Current Liabilities Total is fairly stable compared to the past year. Other Current Assets is likely to rise to about 307 M in 2024, whereas Total Assets are likely to drop slightly above 4.5 B in 2024.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	826.8M	807.3M	928.4M	974.8M
Total Assets	6.4B	6.4B	7.4B	4.5B

Short Long Term Debt Total Total Assets

Amdocs balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock Total Equity	Property Plant And Equipment Gross	Common Stock	Current Deferred Revenue	Other Liab
Total Assets		0.56	0.51	0.95	0.96	0.65	0.2	0.77	0.15	0.43	0.97	0.75	0.44	0.93	-0.88	0.65	0.73	-0.61	0.94	0.81	0.04	0.95	0.64	0.94	0.53	0.95
Short Long Term Debt Total	0.56		0.5	0.44	0.49	0.73	0.53	0.76	-0.05	-0.22	0.68	0.67	-0.25	0.67	-0.76	0.61	0.85	-0.77	0.57	0.15	0.11	0.62	0.73	0.63	0.09	0.47
Other Current Liab	0.51	0.5		0.37	0.32	0.85	0.79	0.78	-0.31	-0.05	0.59	0.77	0.03	0.37	-0.71	0.86	0.71	-0.83	0.67	0.19	-0.34	0.51	0.85	0.56	0.56	0.51
Total Current Liabilities	0.95	0.44	0.37		0.97	0.48	-0.01	0.69	0.32	0.48	0.88	0.65	0.52	0.92	-0.77	0.47	0.65	-0.46	0.82	0.86	0.13	0.94	0.47	0.92	0.47	0.87
Total Stockholder Equity	0.96	0.49	0.32	0.97		0.46	-0.06	0.67	0.35	0.54	0.87	0.65	0.55	0.93	-0.75	0.45	0.66	-0.41	0.8	0.89	0.23	0.92	0.45	0.9	0.38	0.86
Property Plant And Equipment Net	0.65	0.73	0.85	0.48	0.46		0.82	0.93	-0.35	-0.02	0.74	0.9	0.0	0.55	-0.86	0.98	0.87	-0.95	0.79	0.28	-0.32	0.66	1.0	0.7	0.57	0.67
Net Debt	0.2	0.53	0.79	-0.01	-0.06	0.82		0.6	-0.62	-0.47	0.39	0.57	-0.45	0.13	-0.58	0.79	0.53	-0.84	0.48	-0.28	-0.52	0.2	0.82	0.26	0.41	0.3
Retained Earnings	0.77	0.76	0.78	0.69	0.67	0.93	0.6		-0.13	0.1	0.81	0.95	0.16	0.72	-0.9	0.89	0.95	-0.9	0.81	0.49	-0.12	0.82	0.93	0.85	0.54	0.75
Accounts Payable	0.15	-0.05	-0.31	0.32	0.35	-0.35	-0.62	-0.13		0.5	0.0	-0.15	0.47	0.19	0.16	-0.34	-0.01	0.41	-0.08	0.44	0.11	0.17	-0.35	0.11	-0.35	-0.06
Cash	0.43	-0.22	-0.05	0.48	0.54	-0.02	-0.47	0.1	0.5		0.2	0.17	0.96	0.21	-0.03	0.1	0.06	0.24	0.27	0.84	0.14	0.33	-0.03	0.3	0.21	0.31
Non Current Assets Total	0.97	0.68	0.59	0.88	0.87	0.74	0.39	0.81	0.0	0.2		0.76	0.2	0.93	-0.96	0.71	0.77	-0.74	0.97	0.63	-0.01	0.93	0.73	0.93	0.51	0.94
Non Currrent Assets Other	0.75	0.67	0.77	0.65	0.65	0.9	0.57	0.95	-0.15	0.17	0.76		0.25	0.66	-0.83	0.9	0.91	-0.82	0.79	0.52	-0.19	0.78	0.9	0.81	0.56	0.77
Cash And Short Term Investments	0.44	-0.25	0.03	0.52	0.55	0.0	-0.45	0.16	0.47	0.96	0.2	0.25		0.22	-0.05	0.13	0.1	0.19	0.29	0.87	0.05	0.37	-0.01	0.34	0.34	0.37
Net Receivables	0.93	0.67	0.37	0.92	0.93	0.55	0.13	0.72	0.19	0.21	0.93	0.66	0.22		-0.87	0.49	0.74	-0.58	0.83	0.67	0.23	0.93	0.54	0.92	0.34	0.86
Common Stock Shares Outstanding	-0.88	-0.76	-0.71	-0.77	-0.75	-0.86	-0.58	-0.9	0.16	-0.03	-0.96	-0.83	-0.05	-0.87		-0.81	-0.84	0.89	-0.94	-0.48	0.06	-0.89	-0.85	-0.91	-0.53	-0.88
Non Current Liabilities Total	0.65	0.61	0.86	0.47	0.45	0.98	0.79	0.89	-0.34	0.1	0.71	0.9	0.13	0.49	-0.81		0.8	-0.89	0.81	0.34	-0.4	0.63	0.98	0.67	0.64	0.69
Other Current Assets	0.73	0.85	0.71	0.65	0.66	0.87	0.53	0.95	-0.01	0.06	0.77	0.91	0.1	0.74	-0.84	0.8		-0.83	0.72	0.44	-0.05	0.78	0.86	0.8	0.4	0.65
Other Stockholder Equity	-0.61	-0.77	-0.83	-0.46	-0.41	-0.95	-0.84	-0.9	0.41	0.24	-0.74	-0.82	0.19	-0.58	0.89	-0.89	-0.83		-0.76	-0.14	0.25	-0.62	-0.95	-0.67	-0.53	-0.64
Total Liab	0.94	0.57	0.67	0.82	0.8	0.79	0.48	0.81	-0.08	0.27	0.97	0.79	0.29	0.83	-0.94	0.81	0.72	-0.76		0.64	-0.18	0.88	0.79	0.89	0.64	0.95
Total Current Assets	0.81	0.15	0.19	0.86	0.89	0.28	-0.28	0.49	0.44	0.84	0.63	0.52	0.87	0.67	-0.48	0.34	0.44	-0.14	0.64		0.15	0.75	0.26	0.72	0.43	0.72
Short Term Debt	0.04	0.11	-0.34	0.13	0.23	-0.32	-0.52	-0.12	0.11	0.14	-0.01	-0.19	0.05	0.23	0.06	-0.4	-0.05	0.25	-0.18	0.15		0.09	-0.32	0.05	-0.41	-0.09
Common Stock Total Equity	0.95	0.62	0.51	0.94	0.92	0.66	0.2	0.82	0.17	0.33	0.93	0.78	0.37	0.93	-0.89	0.63	0.78	-0.62	0.88	0.75	0.09		0.65	1.0	0.44	0.89
Property Plant And Equipment Gross	0.64	0.73	0.85	0.47	0.45	1.0	0.82	0.93	-0.35	-0.03	0.73	0.9	-0.01	0.54	-0.85	0.98	0.86	-0.95	0.79	0.26	-0.32	0.65		0.69	0.57	0.67
Common Stock	0.94	0.63	0.56	0.92	0.9	0.7	0.26	0.85	0.11	0.3	0.93	0.81	0.34	0.92	-0.91	0.67	0.8	-0.67	0.89	0.72	0.05	1.0	0.69		0.47	0.91
Current Deferred Revenue	0.53	0.09	0.56	0.47	0.38	0.57	0.41	0.54	-0.35	0.21	0.51	0.56	0.34	0.34	-0.53	0.64	0.4	-0.53	0.64	0.43	-0.41	0.44	0.57	0.47		0.63
Other Liab	0.95	0.47	0.51	0.87	0.86	0.67	0.3	0.75	-0.06	0.31	0.94	0.77	0.37	0.86	-0.88	0.69	0.65	-0.64	0.95	0.72	-0.09	0.89	0.67	0.91	0.63

Click cells to compare fundamentals

Amdocs Account Relationship Matchups

Amdocs balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.3B	6.5B	6.4B	6.4B	7.4B	4.5B
Other Current Liab	794.4M	886.6M	821.3M	849.4M	976.9M	1.0B
Total Current Liabilities	1.2B	1.3B	1.3B	1.4B	1.6B	1.0B
Total Stockholder Equity	3.6B	3.6B	3.5B	3.5B	4.1B	2.8B
Property Plant And Equipment Net	903.4M	931.9M	971.2M	951.9M	1.1B	1.1B
Net Debt	50.0M	172.1M	253.5M	287.2M	258.5M	271.4M
Retained Earnings	5.3B	5.9B	6.2B	6.5B	7.5B	7.9B
Accounts Payable	930.3M	121.2M	134.4M	293.3M	337.3M	428.4M
Cash	983.2M	709.1M	573.4M	520.1M	598.1M	720.1M
Non Current Assets Total	4.3B	4.4B	4.4B	4.5B	5.2B	2.6B
Non Currrent Assets Other	488.6M	630.7M	574.9M	631.6M	726.3M	762.6M
Cash And Short Term Investments	983.9M	965.6M	818.0M	742.5M	853.9M	1.0B
Net Receivables	861.0M	866.8M	946.8M	944.5M	1.1B	618.6M
Common Stock Shares Outstanding	133.2M	128.0M	121.9M	118.5M	106.6M	144.3M
Liabilities And Stockholders Equity	6.3B	6.5B	6.4B	6.4B	7.4B	4.5B
Non Current Liabilities Total	1.5B	1.6B	1.6B	1.5B	1.7B	1.8B
Other Current Assets	229.6M	235.1M	238.4M	224.6M	258.3M	307.0M
Other Stockholder Equity	(1.7B)	(2.3B)	(2.6B)	(3.0B)	(2.7B)	(2.5B)
Total Liab	2.7B	2.9B	2.8B	2.9B	3.3B	1.7B
Total Current Assets	2.1B	2.1B	2.0B	1.9B	2.2B	1.9B
Short Term Debt	159.1M	58.7M	43.3M	40.0M	46.0M	43.7M
Property Plant And Equipment Gross	903.4M	931.9M	971.2M	951.9M	1.1B	1.1B
Accumulated Other Comprehensive Income	11.7M	9.3M	(72.5M)	(53.3M)	(47.9M)	(45.5M)
Common Stock	4.5M	4.5M	4.5M	4.6M	5.3M	4.4M
Current Deferred Revenue	126.8M	237.4M	253.7M	170.6M	196.2M	184.3M
Other Liab	542.4M	586.2M	750.3M	793.9M	913.0M	469.4M
Other Assets	423.9M	488.6M	630.7M	574.9M	661.2M	386.6M
Good Will	2.6B	2.6B	2.7B	2.7B	3.2B	1.9B
Intangible Assets	296.3M	259.0M	178.3M	181.5M	163.4M	317.6M
Property Plant Equipment	354.0M	723.6M	931.9M	971.2M	1.1B	1.2B
Short Term Investments	752K	256.5M	244.6M	222.5M	200.2M	266.3M
Net Tangible Assets	660.6M	567.8M	711.0M	676.6M	609.0M	676.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GOOG	Alphabet Inc Class C
BAC	Bank of America
DD	Dupont De Nemours

When determining whether Amdocs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amdocs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amdocs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amdocs Stock:

How To Invest In Amdocs

Details

Is Amdocs Stock a good investment?

Details

What is Amdocs' Net Worth?

Details

Largest Software - Infrastructure Companies

View

Largest Information Technology Companies

View

For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Amdocs Stock analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.

	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk

Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.18)

Dividend Share

1.784

Earnings Share

4.46

Revenue Per Share

42.22

Quarterly Revenue Growth

0.018

The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amdocs Historical Balance Sheet

Amdocs Inventory

1.21

About Amdocs Balance Sheet Analysis

Amdocs Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Accounts Payable

Net Invested Capital

Amdocs balance sheet Correlations

Amdocs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Amdocs balance sheet Accounts

Also Currently Popular

Complementary Tools for Amdocs Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Common Stock	+ 1.0	Common Stock Total Equity
Non Current Liabilities Total	+ 0.98	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.98	Non Current Liabilities Total
Non Current Assets Total	+ 0.97	Total Assets
Total Stockholder Equity	+ 0.97	Total Current Liabilities

Common Stock Shares Outstanding	- 0.96	Non Current Assets Total
Property Plant And Equipment Gross	- 0.95	Other Stockholder Equity
Other Stockholder Equity	- 0.95	Property Plant And Equipment Net
Total Liab	- 0.94	Common Stock Shares Outstanding
Common Stock	- 0.91	Common Stock Shares Outstanding
Other Stockholder Equity	- 0.9	Retained Earnings